F. Pommier - Concepedia

Author

F. Pommier

Novartis (Switzerland)

Also Known As

F POMMIER, F Pommier, F. Pommier, Francoise Pommier, Françoise Pommier

Publications

897

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Novartis (France)Novartis (United States)Los Angeles Clinical Trials Tris Pharma (United States)

About

F. Pommier is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and chromatography.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	21	555
2	Biochemistry	3	3	71
3	Health Sciences	1	1	30
4	Social Sciences	1	1	10
5	Chemistry	1	1	12

F. Pommier

Publications

837

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients Gilbert Lefèvre, G Sędek, S. S. Jhee, Clinical Pharmacology & Therapeutics	2007	126
Quantitative determination of rivastigmine and its major metabolite in human plasma by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry F. Pommier, R FRIGOLA Journal of Chromatography B Major MetaboliteGas ChromatographyMedicineMass SpectrometryMetabolomic Profiling	2003	67
Estimation of the Absolute Bioavailability of Rivastigmine in Patients with Mild to Moderate Dementia of the Alzheimer???s Type Mohammad Sharif Hossain, Stanford S. Jhee, Thomas Shiovitz, Clinical Pharmacokinetics Neurodegenerative DiseasesAlzheimer's DiseaseGeriatricsMedicineDementia	2002	59
Percutaneous absorption of diclofenac in healthy volunteers after single and repeated topical application of diclofenac Emulgel A. Sioufi, F. Pommier, F. Boschet, Biopharmaceutics & Drug Disposition	1994	47
Determination of benazepril, a new angiotensin-converting enzyme inhibitor, and its active metabolite, benazeprilat, in plasma and urine by capillary gas chromatography-mass-selective detection A. Sioufi, F. Pommier, G. Kaiser, Journal of Chromatography B Biomedical Sciences and Applications Therapeutic Drug MonitoringMedicinal ChemistryBioanalysisPharmacologyClinical Pharmacology	1988	46
Pharmacokinetics and Bioavailability of the Novel Rivastigmine Transdermal Patch Versus Rivastigmine Oral Solution in Healthy Elderly Subjects Gilbert Lefèvre, F. Pommier, G Sędek, The Journal of Clinical Pharmacology Translational MedicineHealthy Elderly SubjectsPharmacologyTopical DrugPharmacotherapy	2008	44
Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects Yanling He, Monica Ligueros‐Saylan, Gangadhar Sunkara, The Journal of Clinical Pharmacology	2007	43
Gas chromatographic determination of amantadine hydrochloride (symmetrel) in human plasma and urine A. Sioufi, F. Pommier Journal of Chromatography B Biomedical Sciences and Applications Gas ChromatographyMedicineHuman PlasmaGas Chromatographic DeterminationAnalytical Chemistry	1980	41
Determination of diclofenac in plasma and urine by capillary gas chromatography—mass spectrometry with possible simultaneous determination of deuterium-labelled diclofenac A. Sioufi, F. Pommier, J. Godbillon Journal of Chromatography B Biomedical Sciences and Applications Gas ChromatographyMedicineDeuterium-labelled DiclofenacMass SpectrometryAnalytical Chemistry	1991	33
Ketoconazole Increases Fingolimod Blood Levels in a Drug Interaction via CYP4F2 Inhibition John M. Kovarik, Kiran Dole, Gilles‐Jacques Rivière, The Journal of Clinical Pharmacology Healthy SubjectsCyp4f2 InhibitionPharmacotherapyFingolimod Blood LevelsExperimental Pharmacology	2009	30

Page 1